34900737|t|Impact of TNF-alpha Gene Polymorphisms on Pancreatic and Non-Small Cell Lung Cancer-Induced Cachexia in Adult Egyptian Patients: A Focus on Pathogenic Trajectories.
34900737|a|BACKGROUND: Cachexia is a frequent syndrome in pancreatic and non-small cell lung (NSCL) cancer patients. The storm of cancer-induced inflammatory cytokines, in particular TNF-alpha, is a crucial pathogenic mechanism. Among the molecular alterations accused of cancer-induced cachexia, TNF-alpha 308 G/A (rs1800629) and -1031T/C (rs1799964) are single-nucleotide polymorphisms (SNPs) within the gene encoding this pro-inflammatory cytokine. Recent studies have demonstrated the crucial role of non-coding microRNAs (miRNAs) in pathogenesis of different diseases including cachexia. Moreover, the mechanistic cytokine signaling pathway of miR-155, as a TNF-alpha regulator, supports the involvement of SOCS1, TAB2, and Foxp3, which are direct targets of TNF-alpha gene. AIM: A case-control study (NCT04131478) was conducted primarily to determine the incidence of TNF-alpha 308 G/A (rs1800629) and -1031T/C (rs1799964) gene polymorphisms in adult Egyptian patients with local/advanced or metastatic pancreatic or NSCL cancer and investigate both as cachexia risk factors. The association of gene polymorphism with cachexia severity and the expression of miR-155 in cachectic patients were analyzed. A mechanistic investigation of the cytokine signaling pathway, involving SOCS1, TAB2, and Foxp3, was also performed. RESULTS: In both pancreatic and NSCL cancer cohorts, the mutant TNF-alpha variant of 308 G/A was positively associated with cachexia; on the contrary, that of 1031T/C was negatively associated with cachexia in the NSCL cancer patients. MiR-155 was higher in cachexia and in alignment with its severity in the cachectic group as compared with the non-cachectic group in both the pancreatic and NSCL cancer patients. Though TAB2 did not change to any significant extent in cachectic patients, the levels of SOCS1 and Foxp3 were significantly lower in the cachectic group as compared with the non-cachectic group. CONCLUSION: Carriers of the A allele 308 G/A gene and high miR-155 are at greater risk of cachexia in both the pancreatic and NSCL cancer patients; however, the mutant variant of 1031T/C gene is protective against cachexia in the NSCL cancer patients. Finally, high levels of miR-155 in the cachectic group lead to negative feedback inhibition of both SOCS1 and Foxp3 in both the pancreatic and NSCL cancer patients.
34900737	10	19	TNF-alpha	Gene	7124
34900737	42	83	Pancreatic and Non-Small Cell Lung Cancer	Disease	MESH:D002289
34900737	92	100	Cachexia	Disease	MESH:D002100
34900737	119	127	Patients	Species	9606
34900737	177	185	Cachexia	Disease	MESH:D002100
34900737	212	260	pancreatic and non-small cell lung (NSCL) cancer	Disease	MESH:D002289
34900737	261	269	patients	Species	9606
34900737	284	290	cancer	Disease	MESH:D009369
34900737	299	321	inflammatory cytokines	Disease	MESH:D000080424
34900737	337	346	TNF-alpha	Gene	7124
34900737	426	432	cancer	Disease	MESH:D009369
34900737	441	449	cachexia	Disease	MESH:D002100
34900737	461	468	308 G/A	DNAMutation	tmVar:c|SUB|G|308|A;HGVS:c.308G>A;VariantGroup:1;CorrespondingGene:7124;RS#:1800629;CorrespondingSpecies:9606;CA#:3713873
34900737	470	479	rs1800629	SNP	tmVar:rs1800629;VariantGroup:1;CorrespondingGene:7124;RS#:1800629;CorrespondingSpecies:9606
34900737	485	493	-1031T/C	DNAMutation	tmVar:c|SUB|T|-1031|C;HGVS:c.-1031T>C;VariantGroup:0;CorrespondingGene:7124;RS#:1799964;CorrespondingSpecies:9606;CA#:12266080
34900737	495	504	rs1799964	SNP	tmVar:rs1799964;VariantGroup:0;CorrespondingGene:7124;RS#:1799964;CorrespondingSpecies:9606
34900737	583	595	inflammatory	Disease	MESH:D007249
34900737	737	745	cachexia	Disease	MESH:D002100
34900737	803	810	miR-155	Gene	406947
34900737	817	826	TNF-alpha	Gene	7124
34900737	866	871	SOCS1	Gene	8651
34900737	873	877	TAB2	Gene	23118
34900737	883	888	Foxp3	Gene	50943
34900737	918	927	TNF-alpha	Gene	7124
34900737	1038	1045	308 G/A	DNAMutation	tmVar:c|SUB|G|308|A;HGVS:c.308G>A;VariantGroup:1;CorrespondingGene:7124;RS#:1800629;CorrespondingSpecies:9606;CA#:3713873
34900737	1047	1056	rs1800629	SNP	tmVar:rs1800629;VariantGroup:1;CorrespondingGene:7124;RS#:1800629;CorrespondingSpecies:9606
34900737	1062	1070	-1031T/C	DNAMutation	tmVar:c|SUB|T|-1031|C;HGVS:c.-1031T>C;VariantGroup:0;CorrespondingGene:7124;RS#:1799964;CorrespondingSpecies:9606;CA#:12266080
34900737	1072	1081	rs1799964	SNP	tmVar:rs1799964;VariantGroup:0;CorrespondingGene:7124;RS#:1799964;CorrespondingSpecies:9606
34900737	1120	1128	patients	Species	9606
34900737	1163	1188	pancreatic or NSCL cancer	Disease	MESH:D002289
34900737	1213	1221	cachexia	Disease	MESH:D002100
34900737	1278	1286	cachexia	Disease	MESH:D002100
34900737	1318	1325	miR-155	Gene	406947
34900737	1329	1338	cachectic	Disease	
34900737	1339	1347	patients	Species	9606
34900737	1436	1441	SOCS1	Gene	8651
34900737	1443	1447	TAB2	Gene	23118
34900737	1453	1458	Foxp3	Gene	50943
34900737	1497	1523	pancreatic and NSCL cancer	Disease	MESH:D002289
34900737	1544	1553	TNF-alpha	Gene	7124
34900737	1565	1570	308 G	DNAMutation	tmVar:c|Allele|G|308;VariantGroup:1;CorrespondingGene:7124;RS#:1800629;CorrespondingSpecies:9606
34900737	1604	1612	cachexia	Disease	MESH:D002100
34900737	1639	1644	1031T	DNAMutation	tmVar:c|Allele|T|1031;VariantGroup:0;CorrespondingGene:7124;RS#:1799964;CorrespondingSpecies:9606
34900737	1678	1686	cachexia	Disease	MESH:D002100
34900737	1694	1705	NSCL cancer	Disease	MESH:D002289
34900737	1706	1714	patients	Species	9606
34900737	1716	1723	MiR-155	Gene	406947
34900737	1738	1746	cachexia	Disease	MESH:D002100
34900737	1789	1798	cachectic	Disease	
34900737	1830	1839	cachectic	Disease	
34900737	1858	1884	pancreatic and NSCL cancer	Disease	MESH:D002289
34900737	1885	1893	patients	Species	9606
34900737	1902	1906	TAB2	Gene	23118
34900737	1951	1960	cachectic	Disease	
34900737	1961	1969	patients	Species	9606
34900737	1985	1990	SOCS1	Gene	8651
34900737	1995	2000	Foxp3	Gene	50943
34900737	2033	2042	cachectic	Disease	
34900737	2074	2083	cachectic	Disease	
34900737	2128	2135	308 G/A	DNAMutation	tmVar:c|SUB|G|308|A;HGVS:c.308G>A;VariantGroup:1;CorrespondingGene:7124;RS#:1800629;CorrespondingSpecies:9606;CA#:3713873
34900737	2150	2157	miR-155	Gene	406947
34900737	2181	2189	cachexia	Disease	MESH:D002100
34900737	2202	2228	pancreatic and NSCL cancer	Disease	MESH:D002289
34900737	2229	2237	patients	Species	9606
34900737	2270	2277	1031T/C	DNAMutation	tmVar:c|SUB|T|1031|C;HGVS:c.1031T>C;VariantGroup:0;CorrespondingGene:7124;RS#:1799964;CorrespondingSpecies:9606;CA#:12266080
34900737	2305	2313	cachexia	Disease	MESH:D002100
34900737	2321	2332	NSCL cancer	Disease	MESH:D002289
34900737	2333	2341	patients	Species	9606
34900737	2367	2374	miR-155	Gene	406947
34900737	2382	2391	cachectic	Disease	
34900737	2443	2448	SOCS1	Gene	8651
34900737	2453	2458	Foxp3	Gene	50943
34900737	2471	2497	pancreatic and NSCL cancer	Disease	MESH:D002289
34900737	2498	2506	patients	Species	9606
34900737	Association	RS#:1799964;HGVS:c.-1031T>C;CorrespondingGene:7124	MESH:D009369
34900737	Association	MESH:D002100	7124
34900737	Association	MESH:D002100	RS#:1799964;CorrespondingGene:7124
34900737	Association	RS#:1799964;CorrespondingGene:7124	MESH:D002289
34900737	Association	RS#:1799964;HGVS:c.-1031T>C;CorrespondingGene:7124	MESH:D007249
34900737	Association	MESH:D002289	RS#:1799964;CorrespondingGene:7124
34900737	Association	RS#:1799964;HGVS:c.-1031T>C;CorrespondingGene:7124	MESH:D002289
34900737	Association	RS#:1800629;HGVS:c.308G>A;CorrespondingGene:7124	RS#:1799964;CorrespondingGene:7124
34900737	Negative_Correlation	RS#:1799964;HGVS:c.1031T>C;CorrespondingGene:7124	MESH:D002100
34900737	Association	RS#:1800629;HGVS:c.308G>A;CorrespondingGene:7124	MESH:D002289
34900737	Association	RS#:1799964;HGVS:c.-1031T>C;CorrespondingGene:7124	RS#:1799964;CorrespondingGene:7124
34900737	Association	MESH:D007249	RS#:1799964;CorrespondingGene:7124
34900737	Positive_Correlation	RS#:1799964;HGVS:c.-1031T>C;CorrespondingGene:7124	MESH:D002100
34900737	Association	50943	7124
34900737	Association	MESH:D002289	7124
34900737	Positive_Correlation	RS#:1800629;HGVS:c.308G>A;CorrespondingGene:7124	MESH:D002100
34900737	Association	7124	8651
34900737	Association	23118	7124
34900737	Association	RS#:1800629;HGVS:c.308G>A;CorrespondingGene:7124	MESH:D007249
34900737	Association	MESH:D002289	RS#:1800629;CorrespondingGene:7124
34900737	Association	RS#:1799964;HGVS:c.-1031T>C;CorrespondingGene:7124	RS#:1800629;CorrespondingGene:7124
34900737	Negative_Correlation	RS#:1799964;CorrespondingGene:7124	MESH:D002100
34900737	Positive_Correlation	RS#:1800629;CorrespondingGene:7124	MESH:D002100
34900737	Association	MESH:D009369	7124
34900737	Association	406947	7124
34900737	Positive_Correlation	MESH:D002100	RS#:1800629;CorrespondingGene:7124
34900737	Association	RS#:1800629;CorrespondingGene:7124	MESH:D002289
34900737	Association	MESH:D009369	7124
34900737	Association	MESH:D002100	7124
34900737	Association	MESH:D002289	7124
34900737	Association	MESH:D007249	7124

